Literature DB >> 35379932

All about NASH: disease biology, targets, and opportunities on the road to NASH drugs.

H Eric Xu1, Jin-Song Guo2.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35379932      PMCID： PMC9061727          DOI： 10.1038/s41401-022-00900-y

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN： 1671-4083            Impact factor:   7.169


× No keyword cloud information.
  1 in total

Review 1.  Histological assessment based on liver biopsy: the value and challenges in NASH drug development.

Authors:  Xiao-Fei Tong; Qian-Yi Wang; Xin-Yan Zhao; Ya-Meng Sun; Xiao-Ning Wu; Li-Ling Yang; Zheng-Zhao Lu; Xiao-Juan Ou; Ji-Dong Jia; Hong You
Journal:  Acta Pharmacol Sin       Date:  2022-02-14       Impact factor: 7.169
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.